Expressing support for testing for antiphospholipid syndrome (APS) as a standard part of prenatal screening, and for other purposes.
119-HRES-685119th CongressIntroduced Sep 9, 2025Health
Market Probability
No market
Status
Introduced
Committee
Floor Vote
Other Chamber
Signed
Referred to the House Committee on Energy and Commerce.
Sponsor
Rep. Cammack, Kat [R-FL-3](R-FL-3)8 cosponsors
Actions (3)
Referred to the House Committee on Energy and Commerce.
Sep 9, 2025House floor actions
Submitted in House
Sep 9, 2025Library of Congress
Submitted in House
Sep 9, 2025Library of Congress